摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Benzyl-1-(3-dimethylamino-propyl)-1-(7,8-dimethyl-2-oxo-1,2-dihydro-quinolin-3-ylmethyl)-urea

中文名称
——
中文别名
——
英文名称
3-Benzyl-1-(3-dimethylamino-propyl)-1-(7,8-dimethyl-2-oxo-1,2-dihydro-quinolin-3-ylmethyl)-urea
英文别名
3-benzyl-1-[3-(dimethylamino)propyl]-1-[(7,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]urea
3-Benzyl-1-(3-dimethylamino-propyl)-1-(7,8-dimethyl-2-oxo-1,2-dihydro-quinolin-3-ylmethyl)-urea化学式
CAS
——
化学式
C25H32N4O2
mdl
——
分子量
420.5
InChiKey
MTTWXLYEPWOSKV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    31
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    64.7
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Inhibitors of N-linked glycosylation and methods using same
    申请人:YALE UNIVERSITY
    公开号:US11219625B2
    公开(公告)日:2022-01-11
    The present invention includes novel compounds and methods for preventing or treating diseases associated with N-linked glycosylation in a subject in need thereof. The methods comprise administering to the subject an effective amount of at least one compound of the invention.
    本发明包括用于预防或治疗有需要的受试者与N-连接糖基化相关的疾病的新型化合物和方法。这些方法包括向受试者施用有效量的至少一种本发明化合物。
  • Inhibitors of N-Linked Glycosylation and Methods Using Same
    申请人:YALE UNIVERSITY
    公开号:US20190000858A1
    公开(公告)日:2019-01-03
    The present invention includes novel compounds and methods for preventing or treating diseases associated with N-linked glycosylation in a subject in need thereof. The methods comprise administering to the subject an effective amount of at least one compound of the invention.
  • [EN] INHIBITORS OF N-LINKED GLYCOSYLATION AND METHODS USING SAME<br/>[FR] INHIBITEURS DE GLYCOSYLATION À LIAISON EN N ET PROCÉDÉS LES UTILISANT
    申请人:UNIV YALE
    公开号:WO2017019540A2
    公开(公告)日:2017-02-02
    The present invention includes novel compounds and methods for preventing or treating diseases associated with N-linked glycosylation in a subject in need thereof. The methods comprise administering to the subject an effective amount of at least one compound of the invention.
查看更多